Literature DB >> 15178954

Isolated executive impairment and associated frontal neuropathology.

Julene K Johnson1, Brent A Vogt, Ronald Kim, Carl W Cotman, Elizabeth Head.   

Abstract

Cognitive impairment in the absence of dementia is common in elderly individuals and is most often studied in the context of an isolated impairment in memory. In the current study, we report the neuropsychological and neuropathological features of a nondemented elderly individual with isolated impairment on a test of executive function (i.e., Trail Making Test) and preserved memory, language, and visuospatial function. Postmortem studies indicated that cortical neurofibrillary tangles (NFT) varied considerably, and some regions contained large numbers of neuritic senile plaques. Semiquantitative immunohistochemistry showed higher NFT and amyloid-beta (Abeta) loads in the frontal cortex relative to the temporal, entorhinal, occipital, and parietal cortices. A survey of the entire cingulate gyrus showed a wide dispersion of Abeta42 with the highest concentration in the perigenual part of the anterior cingulate cortex; Abeta appeared to be linked with neuron loss and did not overlap with the heaviest neuritic degeneration. The current case may represent a nonmemory presentation of mild cognitive impairment (executive mild cognitive impairment) that is associated with frontal and anterior cingulate pathology and may be an early stage of the frontal variant of Alzheimer disease. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178954      PMCID: PMC2637356          DOI: 10.1159/000078183

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  13 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

Authors:  J L Price; P B Davis; J C Morris; D L White
Journal:  Neurobiol Aging       Date:  1991 Jul-Aug       Impact factor: 4.673

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

Review 4.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

5.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

6.  Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging.

Authors:  F W Unverzagt; S Gao; O Baiyewu; A O Ogunniyi; O Gureje; A Perkins; C L Emsley; J Dickens; R Evans; B Musick; K S Hall; S L Hui; H C Hendrie
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

7.  Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.

Authors:  H Yamaguchi; S Sugihara; A Ogawa; N Oshima; Y Ihara
Journal:  J Neuropathol Exp Neurol       Date:  2001-07       Impact factor: 3.685

8.  Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis.

Authors:  L Gustafson
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

9.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.

Authors:  A Brun
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

View more
  11 in total

1.  Neuropsychological performance within-person variability is associated with reduced treatment consent capacity.

Authors:  Ronald J Gurrera; Michele J Karel; Armin R Azar; Jennifer Moye
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-03       Impact factor: 4.105

2.  Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

3.  Executive function, more than global cognition, predicts functional decline and mortality in elderly women.

Authors:  Julene K Johnson; Li-Yung Lui; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-10       Impact factor: 6.053

4.  Trail Making Test predicts physical impairment and mortality in older persons.

Authors:  Rosamaria Vazzana; Stefania Bandinelli; Fabrizio Lauretani; Stefano Volpato; Fulvio Lauretani; Angelo Di Iorio; Michele Abate; Anna Maria Corsi; Yuri Milaneschi; Jack M Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2010-04       Impact factor: 5.562

5.  Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment.

Authors:  Julene K Johnson; Judy Pa; Adam L Boxer; Joel H Kramer; Katie Freeman; Kristine Yaffe
Journal:  Dement Geriatr Cogn Disord       Date:  2010-10-12       Impact factor: 2.959

6.  Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI.

Authors:  Linda L Chao; Judy Pa; Audrey Duarte; Norbert Schuff; Michael W Weiner; Joel H Kramer; Bruce L Miller; Katie M Freeman; Julene K Johnson
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

Review 7.  Amyloid imaging in atypical presentations of Alzheimer's disease.

Authors:  David A Wolk
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

8.  Neurogranin as a predictor of memory and executive function decline in MCI patients.

Authors:  Alison Headley; Andres De Leon-Benedetti; Chuanhui Dong; Bonnie Levin; David Loewenstein; Christian Camargo; Tatjana Rundek; Henrik Zetterberg; Kaj Blennow; Clinton B Wright; Xiaoyan Sun
Journal:  Neurology       Date:  2018-02-02       Impact factor: 9.910

9.  Executive Dysfunction in MCI: Subtype or Early Symptom.

Authors:  Ivar Reinvang; Ramune Grambaite; Thomas Espeseth
Journal:  Int J Alzheimers Dis       Date:  2012-05-30

10.  Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.

Authors:  Jesse Mez; Stephanie Cosentino; Adam M Brickman; Edward D Huey; Jennifer J Manly; Richard Mayeux
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.